Clinical Trials Sponsored by CH CORBIE

Total 635 results

University Hospital, Clermont-Ferrand
Jacques Lacarin Hospital Center; CH Issoire; CH Montluçon; CH Aurillac; CH Moulins; CH Thiers and other collaborators

Completed

Measuring the Impact of the French Version of the Whiplash Book (WHIPLASH)

Whiplash Trauma

France
University Hospital, Caen
CH Lisieux; CH Avranches

Unknown

Incidence of Post Cystography Urinary Tract Infections in the Pediatric Population (IUCPED)

Urinary Infection

France
Therenva
CH Libourne

Completed

Comparison of Lower Limb Endovascular Interventions With and Without the EndoNaut Workstation (COMPAR-MI)

Peripheral Arterial Disease

France
University Hospital, Clermont-Ferrand
Université d'Auvergne; Jacques Lacarin Hospital Center; CRRF La Châtaigneraie; CH... and other collaborators

Unknown

Secondary Postpartum Hemorrhage (SPPH)

Postpartum Hemorrhage | Maternal Morbidity | Delivery | Postpartum Endometritis | Retained Placenta

France
Ch Mont de Marsan

Completed

Follow-up of Osteo-articular Biomarkers After Spa Therapy in a Population With Knee Osteoarthritis and Their Correlation With the Clinical Evolution (BIOMARTHROSE)

Knee Osteoarthritis

France
Ch Mont de Marsan

Completed

Assessment of Fears of Patients Standing at the Operating Block

Anxiety and Fear

France
Ch Mont de Marsan

Withdrawn

Observational Study of the Evaluation of Post Traumatic Stress Post Stroke (SPTD)

Post Traumatic Stress Disorder

France
University Hospital, Clermont-Ferrand
Hospices Civils de Lyon; University Hospital, Grenoble; Hôpital de la Croix-Rousse and other collaborators

Recruiting

Protocol of Diuretics Use in Congestive Therapy in Heart Failure (ProDUCT-HF)

Heart Failure | Chronic Heart Failure | Acute Heart Failure

France
Centre Hospitalier Universitaire, Amiens
CH Montdidier

Recruiting

Intestinal Microbiota Profiling in Severe Acute Alcoholic Hepatitis Patients (HepatAlc-IM)

Corticosteroids | Intestinal Microbiota | Alcohol | Severe Acute Alcoholic Hepatitis

France
Centre Hospitalier Universitaire, Amiens
Centre Hospitalier de Beauvais; University Hospital, Montpellier; University... and other collaborators

Recruiting

Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility (HyperBetashock)

Septic Shock | Tachycardia | Mortality During Septic Shock | Beta-blocker

France
University Hospital, Geneva
Centre Valaisan de Pneumologie, CH-3960Montana

Completed

Bronchoscopy and Bispectral Index (BIS) - Guided Sedation

Bronchoscopy

Switzerland
University Hospital, Montpellier
CHU de la Timone, Marseille, France; CHU Carémeau, Nîmes, France; CHU de Bordeaux... and other collaborators

Recruiting

Biomarkers in Polyradiculoneuropathies (BIP)

Guillain-Barre Syndrome | CIDP

France
Centre Hospitalier Universitaire, Amiens
University Hospital, Lille; Centre Hospitalier Arras; CH Le Havre; CH COMPIEGNE; CENTRE... and other collaborators

Recruiting

The Multitasking Rehabilitation She Enhanced Walking Speed Compared to the Simple Post Stroke Rehabilitation Task (AVC)? (SYNCOMOT)

Subacute Stroke

France
Centre Hospitalier Universitaire de Nīmes
University Hospital, Montpellier; Hospital Center, Alès; CH Bagnols sur Cèze; CH... and other collaborators

Recruiting

Feasability of a Care Pathway Integrating Collaborative Tele-expertise to Prevent Recurring Hospitalisations for Diabetic Patients (TELXCODIA)

Diabetes Mellitus

France
Yale University
Heffter Research Institute; Ceruvia Lifesciences; CH TAC LLC

Completed

Psilocybin for the Treatment of Cluster Headache

Cluster Headache

United States
University Hospital, Clermont-Ferrand
Jacques Lacarin Hospital Center; CH Montluçon

Unknown

Exploration of the Reward System by Functional MRI in Narco-cataplexy Patients With and Without REM Sleep Behavior Disorder (NC-TCSP-IRMf)

Narcolepsy | Cataplexy

France
Novartis
World Health Organization; Avenue Appia 20; CH - 1211 Geneva 27; Switzerland

Completed

Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria

Plasmodium Falciparum Malaria

Kenya, Nigeria, Tanzania
University Hospital, Basel, Switzerland
SenTec AG, Ringstrasse 39, CH-4106 Therwil

Terminated

Accuracy of Non-invasive Continuous CO2-Monitoring

Blood Gas Monitoring, Transcutaneous

Switzerland
Corvia Medical

Recruiting

RESPONDER-HF Trial

Heart Failure | Heart Failure, Diastolic

United States, Germany, Australia, Netherlands, Belgium, Austria
Cordio Medical

Completed

Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients

Coronavirus Infection

Israel
Cordio Medical

Completed

Clinical Evaluation of Cordio App in Adult ADHF Patients

Congestive Heart Failure

Israel
Cordis Corporation

Withdrawn

China Post-market Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INITIATION)

Abdominal Aortic Aneurysms

China
Cordis Corporation

Unknown

CYPRESS - CYPHER for Evaluating Sustained Safety

Coronary Artery Disease

United States
Cordis Corporation

Completed

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary | Peripheral Arteriosclerosis

United States
Cordis Corporation

Completed

ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EU (ECLIPSE)

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary

Germany
Cordis Corporation

Terminated

French Post-Marketing Surveillance Survey (FR E-REGISTRY)

Coronary Artery Disease
Cordis Corporation

Completed

A Study of the Presillion Stent in de Novo Coronary Lesions (PRESILLION)

Coronary Artery Disease

Belgium
Cordis Corporation

Completed

NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions

Coronary Artery Disease

United States
Cordis Corporation

Completed

Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Coronary Artery Disease

United States
Cordis Corporation

Completed

Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial (DESSERT)

Coronary Artery Disease

Italy
Cordis Corporation

Completed

The Study of the Crushing Technique Application Using SES in Coronary Bifurcations. (CACTUS)

Coronary Artery Disease

Italy
Cordis Corporation

Completed

Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)

Coronary Artery Disease

United States
Cordis Corporation

Completed

Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Coronary Artery Disease

United States
Cordis Corporation

Completed

The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)

Coronary Stenosis
Cordis Corporation

Terminated

Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions (DECODE)

Peripheral Vascular Diseases

United States, China, Malaysia, India, Singapore
Cordis Corporation

Completed

The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions. (C-SIRIUS)

Coronary Artery Disease
Cordis Corporation

Completed

The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions. (SVELTE)

Coronary Artery Disease

Switzerland
Cordis Corporation

Completed

The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study. (RAVEL)

Coronary Artery Disease

France
Cordis Corporation

Completed

Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE)

Carotid Artery Disease
Cordis Corporation

Completed

Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX)

Coronary Artery Disease

Brazil
Cordis Corporation

Completed

An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry). (DESCOVER)

Cardiovascular Diseases | Arteriosclerosis | Atherosclerosis | Vascular Disease | Arterial Occlusive Disease

United States
Cordis Corporation

Completed

Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)

Carotid Artery Disease

United States
Cordis Corporation

Completed

CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)

Coronary Artery Disease
Cordis Corporation

Completed

Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)

Abdominal Aortic Aneurysm

United States
Cordio Medical

Recruiting

COMMUNITY STUDY- A Study to Collect Information for the Cordio System

Heart Failure

Israel
Corvia Medical

Recruiting

REDUCE LAP-HF III Corvia Protocol 1701 (REDUCELAPHFIII)

Heart Failure

Germany, Switzerland
Corvia Medical

Active, not recruiting

REDUCE LAP-HFREF TRIAL

Heart Failure

Australia, United States, Czechia
Corvia Medical

Active, not recruiting

REDUCE LAP-HF RANDOMIZED TRIAL I

Heart Failure

United States, Netherlands, Australia, Belgium, United Kingdom
Cordis Corporation

Completed

A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION) (INNOVATION)

Abdominal Aortic Aneurysms

Germany
Corvia Medical

Withdrawn

Extended IASD Investigation: REDUCE LAP-HF IV

Heart Failure With Preserved Ejection Fraction | Heart Failure With Mid Range Ejection Fraction

Clinical Trials Sponsored by CH CORBIE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations